Modeling acute graft-versus-host disease (aGVHD) in murine bone marrow transplantation (BMT) models with MHC disparity.
Scheurer J, Leithäuser F, Debatin KM, Strauss G.
Methods Cell Biol. 2022;168:19-39. doi: 10.1016/bs.mcb.2021.12.007. Epub 2022 Jan 10.
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.
Robinson TM, O'Donnell PV, Fuchs EJ, Luznik L.
Semin Hematol. 2016 Apr;53(2):90-7. doi: 10.1053/j.seminhematol.2016.01.005. Epub 2016 Jan 15.
Treatment of acute and chronic graft-versus-host disease with extracorporeal photopheresis: Update of best practice recommendations from Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and the Italian Transplant Group for Bone Marrow Transplantation, Hematopoietic Stem Cells and Cell Therapy (GITMO).
Colpo A, Marchetti M, Bianco I, Cruciani F, Ipsevich F, Montanari M, Stanghellini MTL; Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and the Italian Transplant Group for Bone Marrow Transplantation, Hematopoietic Stem Cells and Cell Therapy (GITMO).
Transfus Apher Sci. 2024 Oct;63(5):103990. doi: 10.1016/j.transci.2024.103990. Epub 2024 Aug 13.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
McCurdy SR, Kanakry CG, Tsai HL, Gojo I, Smith BD, Gladstone DE, Bolaños-Meade J, Borrello I, Matsui WH, Swinnen LJ, Huff CA, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, Jones RJ, Luznik L.
Biol Blood Marrow Transplant. 2019 Jun;25(6):1128-1135. doi: 10.1016/j.bbmt.2018.12.767. Epub 2018 Dec 30.
Ambivalent role of FasL in murine acute graft-versus-host-disease.
Bernard-Bloch R, Lebrault E, Li X, Sutra Del Galy A, Garcia A, Doliger C, Parietti V, Legembre P, Socié G, Karray S.
J Leukoc Biol. 2023 Sep 1;114(3):205-211. doi: 10.1093/jleuko/qiad040.
Hepatobiliary disease after bone marrow transplant.
Dezan MGF, Cavalcante LN, Cotrim HP, Lyra AC.
Expert Rev Gastroenterol Hepatol. 2023 Feb;17(2):129-143. doi: 10.1080/17474124.2023.2169671. Epub 2023 Feb 2.
Peripheral blood stem cell versus bone marrow graft for patients 60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Devillier R, Galimard JE, Blaise D, Raiola AM, Bramanti S, Grillo G, Pastano R, de Latour RP, Busca A, López-Corral L, Rodríguez AB, Schmid C, Forcade E, Vydra J, Solano C, Bug G, Neubauer A, Charbonnier A, Brissot E, Nagler A, Ciceri F, Mohty M.
Am J Hematol. 2024 Jul;99(7):1250-1256. doi: 10.1002/ajh.27343. Epub 2024 May 23.
Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
Yu X, Liu L, Xie Z, Dong C, Zhao L, Zhang J, Gu J, Zhu HH.
Crit Rev Oncol Hematol. 2019 Jan;133:120-128. doi: 10.1016/j.critrevonc.2018.05.017. Epub 2018 Jun 11.
Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
Konishi T, Kusakabe S, Hino A, Inamoto K, Yoshifuji K, Kiridoshi Y, Takeshita K, Sasajima S, Toya T, Igarashi A, Najima Y, Kobayashi T, Doki N, Motooka D, Nakamura S, Suyama M, Suda W, Shiota A, Atarashi K, Hattori M, Honda K, Yokota T, Ohashi K, Shibayama H, Fukushima K, Kakihana K.
Bone Marrow Transplant. 2021 Jul;56(7):1728-1731. doi: 10.1038/s41409-021-01249-2. Epub 2021 Mar 8.
Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.
Mullen CA.
Leuk Lymphoma. 2002 Mar;43(3):503-10. doi: 10.1080/10428190290011976.
